Company Presentation Tuesday, June 24, at 11:15 a.m. EDT
June 17, 2003--IMPAX Laboratories, Inc. (NASDAQ: IPXL - News) today announced
that management will present at the 13th Annual Wachovia Securities Nantucket
Conference on Tuesday, June 24, 2003 at 11:15 a.m. EDT. The conference will
be held from June 24-27, 2003 at the Harbor House Village in Nantucket, Massachusetts.
Individuals may listen to both the live and archived webcast until July 24,
2003 at the following address: http://www.twst.com/econf/mm/fu13/ipxl.html.
In addition, a link to the live and archived presentation will be posted on
the investor relations portion of the company's website at www.impaxlabs.com.
IMPAX Laboratories, Inc. is a technology based specialty pharmaceutical company
applying its formulation expertise and drug delivery technology to the development
of controlled-release and specialty generics in addition to the development
of branded products. IMPAX markets its generic products through its Global Pharmaceuticals
division and intends to market its branded products through the IMPAX Pharmaceuticals
division. Additionally, where strategically appropriate, IMPAX has developed
marketing partnerships to fully leverage its technology platform. IMPAX Laboratories
is headquartered in Hayward, California, and has a full range of capabilities
in its Hayward and Philadelphia facilities. For more information, please visit
the Company's Web site at: www.impaxlabs.com.